JPY 4440.0
(0.57%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 10.74 Billion JPY | 19.77% |
2022 | 8.96 Billion JPY | 2.35% |
2021 | 8.76 Billion JPY | 22.54% |
2020 | 7.15 Billion JPY | -4.82% |
2019 | 7.51 Billion JPY | -9.62% |
2018 | 8.31 Billion JPY | -17.9% |
2017 | 10.12 Billion JPY | -4.54% |
2016 | 10.6 Billion JPY | 7.84% |
2015 | 9.83 Billion JPY | -2.96% |
2014 | 10.13 Billion JPY | 26.25% |
2013 | 8.02 Billion JPY | 6.63% |
2012 | 7.52 Billion JPY | 18.72% |
2011 | 6.34 Billion JPY | 17.99% |
2010 | 5.37 Billion JPY | -3.88% |
2009 | 5.59 Billion JPY | 6.94% |
2008 | 5.22 Billion JPY | 34.04% |
2007 | 3.9 Billion JPY | 9.42% |
2006 | 3.56 Billion JPY | -10.99% |
2005 | 4 Billion JPY | 38.53% |
2004 | 2.89 Billion JPY | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 12.07 Billion JPY | 12.43% |
2024 Q2 | 11.9 Billion JPY | -1.45% |
2024 Q3 | 12.87 Billion JPY | 8.21% |
2023 Q4 | 10.74 Billion JPY | -2.18% |
2023 Q1 | 10.72 Billion JPY | 19.52% |
2023 Q3 | 10.98 Billion JPY | 0.58% |
2023 FY | 10.74 Billion JPY | 19.77% |
2023 Q2 | 10.91 Billion JPY | 1.85% |
2022 Q2 | 8.95 Billion JPY | -1.68% |
2022 Q4 | 8.96 Billion JPY | 1.44% |
2022 FY | 8.96 Billion JPY | 2.35% |
2022 Q1 | 9.11 Billion JPY | 3.97% |
2022 Q3 | 8.84 Billion JPY | -1.29% |
2021 Q4 | 8.76 Billion JPY | -6.41% |
2021 FY | 8.76 Billion JPY | 22.54% |
2021 Q1 | 8.38 Billion JPY | 17.21% |
2021 Q2 | 8.13 Billion JPY | -2.95% |
2021 Q3 | 9.36 Billion JPY | 15.1% |
2020 Q2 | 7.51 Billion JPY | -2.67% |
2020 Q1 | 7.72 Billion JPY | 2.77% |
2020 FY | 7.15 Billion JPY | -4.82% |
2020 Q4 | 7.15 Billion JPY | 3.52% |
2020 Q3 | 6.9 Billion JPY | -8.08% |
2019 Q4 | 7.51 Billion JPY | -23.69% |
2019 FY | 7.51 Billion JPY | -9.62% |
2019 Q2 | 9.37 Billion JPY | -2.39% |
2019 Q1 | 9.6 Billion JPY | 15.58% |
2019 Q3 | 9.84 Billion JPY | 4.98% |
2018 Q4 | 8.31 Billion JPY | -15.98% |
2018 FY | 8.31 Billion JPY | -17.9% |
2018 Q1 | 11.28 Billion JPY | 11.41% |
2018 Q2 | 9.53 Billion JPY | -15.48% |
2018 Q3 | 9.89 Billion JPY | 3.78% |
2017 Q4 | 10.12 Billion JPY | -2.59% |
2017 Q2 | 10.25 Billion JPY | -8.44% |
2017 Q1 | 11.2 Billion JPY | 5.64% |
2017 Q3 | 10.39 Billion JPY | 1.33% |
2017 FY | 10.12 Billion JPY | -4.54% |
2016 Q3 | 11.71 Billion JPY | -0.37% |
2016 FY | 10.6 Billion JPY | 7.84% |
2016 Q2 | 11.76 Billion JPY | -4.49% |
2016 Q4 | 10.6 Billion JPY | -9.49% |
2016 Q1 | 12.31 Billion JPY | 25.21% |
2015 Q2 | 11.02 Billion JPY | -8.62% |
2015 Q3 | 10.96 Billion JPY | -0.52% |
2015 Q1 | 12.06 Billion JPY | 0.0% |
2015 FY | 9.83 Billion JPY | -2.96% |
2015 Q4 | 9.83 Billion JPY | -10.3% |
2014 Q1 | 8.02 Billion JPY | 7.48% |
2014 FY | 10.13 Billion JPY | 26.25% |
2014 Q3 | 10.88 Billion JPY | 11.63% |
2014 Q2 | 9.75 Billion JPY | 21.45% |
2013 Q4 | 7.46 Billion JPY | -9.0% |
2013 Q1 | 7.52 Billion JPY | 26.22% |
2013 Q2 | 8.02 Billion JPY | 6.63% |
2013 Q3 | 8.2 Billion JPY | 2.24% |
2013 FY | 8.02 Billion JPY | 6.63% |
2012 Q3 | 5.65 Billion JPY | -2.77% |
2012 FY | 7.52 Billion JPY | 18.72% |
2012 Q4 | 5.96 Billion JPY | 5.46% |
2012 Q2 | 5.81 Billion JPY | -8.28% |
2012 Q1 | 6.34 Billion JPY | 10.93% |
2011 Q3 | 6.09 Billion JPY | -3.85% |
2011 FY | 6.34 Billion JPY | 17.99% |
2011 Q1 | 5.37 Billion JPY | 0.67% |
2011 Q2 | 6.34 Billion JPY | 17.99% |
2011 Q4 | 5.71 Billion JPY | -6.25% |
2010 Q1 | 5.59 Billion JPY | 14.17% |
2010 Q3 | 5.19 Billion JPY | -1.67% |
2010 Q4 | 5.33 Billion JPY | 2.81% |
2010 FY | 5.37 Billion JPY | -3.88% |
2010 Q2 | 5.28 Billion JPY | -5.56% |
2009 Q4 | 4.89 Billion JPY | -4.69% |
2009 FY | 5.59 Billion JPY | 6.94% |
2009 Q3 | 5.13 Billion JPY | 0.0% |
2009 Q1 | 5.22 Billion JPY | 49.49% |
2008 FY | 5.22 Billion JPY | 34.04% |
2008 Q4 | 3.49 Billion JPY | 0.0% |
2007 FY | 3.9 Billion JPY | 9.42% |
2006 FY | 3.56 Billion JPY | -10.99% |
2005 FY | 4 Billion JPY | 38.53% |
2004 FY | 2.89 Billion JPY | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 6.71 Billion JPY | -59.923% |
Takeda Pharmaceutical Company Limited | 1209.86 Billion JPY | 99.112% |
Sumitomo Pharma Co., Ltd. | 115.35 Billion JPY | 90.687% |
Shionogi & Co., Ltd. | 64.91 Billion JPY | 83.452% |
Wakamoto Pharmaceutical Co.,Ltd. | 2 Billion JPY | -435.484% |
Nippon Shinyaku Co., Ltd. | 39.11 Billion JPY | 72.535% |
Kaken Pharmaceutical Co., Ltd. | 17.16 Billion JPY | 37.426% |
Eisai Co., Ltd. | 174.65 Billion JPY | 93.849% |
Morishita Jintan Co., Ltd. | 3.18 Billion JPY | -237.268% |
Hisamitsu Pharmaceutical Co., Inc. | 21.17 Billion JPY | 49.273% |
Mochida Pharmaceutical Co., Ltd. | 30.27 Billion JPY | 64.522% |
Fuso Pharmaceutical Industries,Ltd. | 14.2 Billion JPY | 24.363% |
Nippon Chemiphar Co., Ltd. | 10.72 Billion JPY | -0.187% |
Tsumura & Co. | 117.61 Billion JPY | 90.867% |
Kissei Pharmaceutical Co., Ltd. | 26.29 Billion JPY | 59.15% |
Towa Pharmaceutical Co., Ltd. | 101.07 Billion JPY | 89.372% |
Fuji Pharma Co., Ltd. | 19.37 Billion JPY | 44.546% |
Zeria Pharmaceutical Co., Ltd. | 14.48 Billion JPY | 25.865% |
KYORIN Holdings, Inc. | 53.47 Billion JPY | 79.91% |
Taiko Pharmaceutical Co.,Ltd. | 1.95 Billion JPY | -450.307% |
Daito Pharmaceutical Co.,Ltd. | 20.89 Billion JPY | 48.578% |
SymBio Pharmaceuticals Limited | 232.03 Million JPY | -4529.574% |
MedRx Co., Ltd | 10 Million JPY | -107320.0% |
Mizuho Medy Co.,Ltd. | 1.59 Billion JPY | -572.801% |
Solasia Pharma K.K. | 122 Million JPY | -8704.918% |
Modalis Therapeutics Corporation | 6.35 Million JPY | -168985.471% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 20.4 Billion JPY | 47.348% |
Sawai Group Holdings Co., Ltd. | 100 Billion JPY | 89.258% |
Cyfuse Biomedical K.K. | 46.04 Million JPY | -23229.352% |
Toho Holdings Co., Ltd. | 87.28 Billion JPY | 87.693% |
Koa Shoji Holdings Co.,Ltd. | 2.26 Billion JPY | -373.997% |